FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:GUK1-KDM5C

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: GUK1-KDM5C
FusionPDB ID: 35363
FusionGDB2.0 ID: 35363
HgeneTgene
Gene symbol

GUK1

KDM5C

Gene ID

2987

8242

Gene nameguanylate kinase 1lysine demethylase 5C
SynonymsGMKDXS1272E|JARID1C|MRX13|MRXJ|MRXSCJ|MRXSJ|SMCX|XE169
Cytomap

1q42.13

Xp11.22

Type of geneprotein-codingprotein-coding
Descriptionguanylate kinaseATP:GMP phosphotransferaseGMP kinaselysine-specific demethylase 5CJmjC domain-containing protein SMCXJumonji, AT rich interactive domain 1C (RBP2-like)Jumonji/ARID domain-containing protein 1CSmcx homolog, X chromosomeSmcy homolog, X-linkedhistone demethylase JARID1Clysine (K)-specif
Modification date2020032020200313
UniProtAcc

Q16774

Main function of 5'-partner protein: FUNCTION: Catalyzes the phosphorylation of GMP to GDP. Essential enzyme for recycling GMP and indirectly, cyclic GMP (cGMP) (PubMed:31201273). Involved in the cGMP metabolism in photoreceptors (By similarity). It may also have a role in the survival and growth progression of some tumors (PubMed:31201273). In addition to its physiological role, GUK1 is essential for convert prodrugs used for the treatment of cancers and viral infections into their pharmacologically active metabolites, most notably acyclovir, ganciclovir, and 6-thioguanine and its closely related analog 6-mercaptopurine (PubMed:197968, PubMed:6248551, PubMed:6306664). {ECO:0000250|UniProtKB:P46195, ECO:0000269|PubMed:197968, ECO:0000269|PubMed:31201273, ECO:0000269|PubMed:6248551, ECO:0000269|PubMed:6306664}.

P41229

Main function of 5'-partner protein: FUNCTION: Histone demethylase that specifically demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:28262558). Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Participates in transcriptional repression of neuronal genes by recruiting histone deacetylases and REST at neuron-restrictive silencer elements. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:P41230, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:28262558}.
Ensembl transtripts involved in fusion geneENST idsENST00000470040, ENST00000312726, 
ENST00000366716, ENST00000366718, 
ENST00000366721, ENST00000366722, 
ENST00000366723, ENST00000366726, 
ENST00000366730, ENST00000391865, 
ENST00000366728, 
ENST00000375379, 
ENST00000375383, ENST00000375401, 
ENST00000404049, ENST00000452825, 
ENST00000465402, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score14 X 13 X 6=10924 X 5 X 1=20
# samples 165
** MAII scorelog2(16/1092*10)=-2.77082904603249
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/20*10)=1.32192809488736
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: GUK1 [Title/Abstract] AND KDM5C [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: GUK1 [Title/Abstract] AND KDM5C [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)GUK1(228336098)-KDM5C(53228198), # samples:1
Anticipated loss of major functional domain due to fusion event.GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
GUK1-KDM5C seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
GUK1-KDM5C seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
GUK1-KDM5C seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF.
GUK1-KDM5C seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
GUK1-KDM5C seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneGUK1

GO:0006163

purine nucleotide metabolic process

8663313

HgeneGUK1

GO:0006805

xenobiotic metabolic process

6306664

TgeneKDM5C

GO:0034720

histone H3-K4 demethylation

17320160



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:228336098/chrX:53228198)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across GUK1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KDM5C (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000366730GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+429573425053404299
ENST00000366730GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+402973422393138299
ENST00000366730GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+392473421343033299
ENST00000366730GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+324373414532352299
ENST00000366730GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+324373414532352299
ENST00000391865GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+423367224433342299
ENST00000391865GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+3967672361037333
ENST00000391865GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+3862672361037333
ENST00000391865GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+3181672361037333
ENST00000391865GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+3181672361037333
ENST00000366726GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+419163024013300299
ENST00000366726GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+392563042995317
ENST00000366726GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+382063042995317
ENST00000366726GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+313963042995317
ENST00000366726GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+313963042995317
ENST00000312726GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+433677525463445299
ENST00000312726GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+40707752051140311
ENST00000312726GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+39657752051140311
ENST00000312726GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+32847752051140311
ENST00000312726GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+32847752051140311
ENST00000366721GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+413557423453244299
ENST00000366721GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+386957410939309
ENST00000366721GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+376457410939309
ENST00000366721GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+308357410939309
ENST00000366721GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+308357410939309
ENST00000366718GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+452296127323631299
ENST00000366718GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+42569613941326310
ENST00000366718GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+41519613941326310
ENST00000366718GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+34709613941326310
ENST00000366718GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+34709613941326310
ENST00000366716GUK1chr1228336098+ENST00000452825KDM5CchrX53228198+415459323643263299
ENST00000366716GUK1chr1228336098+ENST00000375401KDM5CchrX53228198+388859320982997299
ENST00000366716GUK1chr1228336098+ENST00000404049KDM5CchrX53228198+378359319932892299
ENST00000366716GUK1chr1228336098+ENST00000375379KDM5CchrX53228198+310259313122211299
ENST00000366716GUK1chr1228336098+ENST00000375383KDM5CchrX53228198+310259313122211299

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000366730ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0103152640.9896847
ENST00000366730ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.0048224850.9951775
ENST00000366730ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0049161730.99508375
ENST00000366730ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.0050249780.9949751
ENST00000366730ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.0050249780.9949751
ENST00000391865ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0099469130.9900531
ENST00000391865ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.0063891350.9936108
ENST00000391865ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0066631380.9933369
ENST00000391865ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.007643330.99235666
ENST00000391865ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.007643330.99235666
ENST00000366726ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0103122840.98968774
ENST00000366726ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.0048917870.9951082
ENST00000366726ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0049812540.9950187
ENST00000366726ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.005043270.9949568
ENST00000366726ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.005043270.9949568
ENST00000312726ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0101796230.98982036
ENST00000312726ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.004781880.9952181
ENST00000312726ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0048903460.9951096
ENST00000312726ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.0049714880.99502856
ENST00000312726ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.0049714880.99502856
ENST00000366721ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0102014640.98979855
ENST00000366721ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.0051429080.9948571
ENST00000366721ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0053204580.9946795
ENST00000366721ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.0055703970.9944296
ENST00000366721ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.0055703970.9944296
ENST00000366718ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0108599730.98914003
ENST00000366718ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.005252990.994747
ENST00000366718ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0053914440.9946085
ENST00000366718ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.0055757860.9944243
ENST00000366718ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.0055757860.9944243
ENST00000366716ENST00000452825GUK1chr1228336098+KDM5CchrX53228198+0.0098939010.99010617
ENST00000366716ENST00000375401GUK1chr1228336098+KDM5CchrX53228198+0.0049015830.9950984
ENST00000366716ENST00000404049GUK1chr1228336098+KDM5CchrX53228198+0.0050308380.9949692
ENST00000366716ENST00000375379GUK1chr1228336098+KDM5CchrX53228198+0.0047439640.995256
ENST00000366716ENST00000375383GUK1chr1228336098+KDM5CchrX53228198+0.0047439640.995256

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for GUK1-KDM5C

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
GUK1chr1228336098KDM5CchrX53228198574212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198593212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198630212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198672212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198734212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198775212RSRWMEKELGLYKSDTELLGLSAQDL
GUK1chr1228336098KDM5CchrX53228198961212RSRWMEKELGLYKSDTELLGLSAQDL

Top

Potential FusionNeoAntigen Information of GUK1-KDM5C in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GUK1-KDM5C_228336098_53228198.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:22GLYKSDTEL0.9870.5336918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:13GLYKSDTEL0.9720.7568918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:27GLYKSDTEL0.97170.6273918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:16GLYKSDTEL0.94910.6307918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:11GLYKSDTEL0.9440.7508918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:60GLYKSDTEL0.94390.6455918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:67GLYKSDTEL0.94370.7099918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:30GLYKSDTEL0.94370.7099918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:24GLYKSDTEL0.94370.7099918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:38GLYKSDTEL0.91440.6802918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:04GLYKSDTEL0.85630.6477918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:29GLYKSDTEL0.77120.7111918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:20GLYKSDTEL0.7690.7189918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:35GLYKSDTEL0.75390.7276918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-B13:01GLYKSDTEL0.05310.9312918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-B13:02GLYKSDTEL0.04870.6235918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:22GLYKSDTELL0.96610.5397919
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:16GLYKSDTELL0.90490.6484919
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C05:09KSDTELLGL0.99990.89621221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:15KSDTELLGL0.99980.96781221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C04:06KSDTELLGL0.98890.85251221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:01GLYKSDTEL0.94370.7099918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-B15:04GLYKSDTEL0.92070.912918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:13KSDTELLGL0.86470.94721221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:04KSDTELLGL0.86470.94721221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:03KSDTELLGL0.50670.9861221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:29LYKSDTELL0.22930.97981019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:13LYKSDTELL0.19160.95161019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:67LYKSDTELL0.1580.96581019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:80LYKSDTELL0.1580.96581019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:10LYKSDTELL0.14870.97981019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C05:09YKSDTELLGL0.99970.89531121
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C14:03LYKSDTEL0.81580.9681018
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C14:02LYKSDTEL0.81580.9681018
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C05:01KSDTELLGL0.99990.89621221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C04:03KSDTELLGL0.99990.81921221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:02KSDTELLGL0.99980.96781221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:03GLYKSDTEL0.98790.7321918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C15:05KSDTELLGL0.98690.87081221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C15:02KSDTELLGL0.98570.86381221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-A02:14GLYKSDTEL0.91510.7029918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-B15:73GLYKSDTEL0.91220.9062918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-B15:30GLYKSDTEL0.67950.8132918
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C08:01KSDTELLGL0.50670.9861221
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C14:02LYKSDTELL0.23310.9731019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C14:03LYKSDTELL0.23310.9731019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C06:06LYKSDTELL0.22740.9921019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C07:02LYKSDTELL0.1580.96581019
GUK1-KDM5Cchr1228336098chrX53228198775HLA-C05:01YKSDTELLGL0.99970.89531121

Top

Potential FusionNeoAntigen Information of GUK1-KDM5C in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GUK1-KDM5C_228336098_53228198.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GUK1-KDM5Cchr1228336098chrX53228198775DRB1-0466LGLYKSDTELLGLSA823

Top

Fusion breakpoint peptide structures of GUK1-KDM5C

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4205KELGLYKSDTELLGGUK1KDM5Cchr1228336098chrX53228198775

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of GUK1-KDM5C

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4205KELGLYKSDTELLG-7.20958-7.40908
HLA-B14:023BVN4205KELGLYKSDTELLG-7.20354-7.40304
HLA-B14:023BVN4205KELGLYKSDTELLG-6.53966-7.66106
HLA-B14:023BVN4205KELGLYKSDTELLG-6.07079-7.44279
HLA-B14:023BVN4205KELGLYKSDTELLG-5.7628-8.0567
HLA-B14:023BVN4205KELGLYKSDTELLG-5.74878-7.12078
HLA-B14:023BVN4205KELGLYKSDTELLG-5.42361-6.54501
HLA-B14:023BVN4205KELGLYKSDTELLG-5.23518-7.52908
HLA-B14:023BVN4205KELGLYKSDTELLG-3.35465-5.81645
HLA-B14:023BVN4205KELGLYKSDTELLG-2.73695-5.19875
HLA-B52:013W394205KELGLYKSDTELLG-6.24948-6.44898
HLA-B52:013W394205KELGLYKSDTELLG-6.19528-6.39478
HLA-B52:013W394205KELGLYKSDTELLG-5.84699-6.96839
HLA-B52:013W394205KELGLYKSDTELLG-5.71707-8.01097
HLA-B52:013W394205KELGLYKSDTELLG-5.65619-7.02819
HLA-B52:013W394205KELGLYKSDTELLG-5.53945-6.66085
HLA-B52:013W394205KELGLYKSDTELLG-5.50774-6.62914
HLA-B52:013W394205KELGLYKSDTELLG-5.28389-6.65589
HLA-B52:013W394205KELGLYKSDTELLG-5.23646-7.69826
HLA-B52:013W394205KELGLYKSDTELLG-4.52568-6.81958
HLA-B52:013W394205KELGLYKSDTELLG-4.09311-6.55491
HLA-B52:013W394205KELGLYKSDTELLG-4.01895-4.21845
HLA-B52:013W394205KELGLYKSDTELLG-3.55077-6.01257
HLA-B52:013W394205KELGLYKSDTELLG-3.40657-5.70047
HLA-B52:013W394205KELGLYKSDTELLG-3.13498-4.50698
HLA-A11:014UQ24205KELGLYKSDTELLG-9.73183-10.8532
HLA-A11:014UQ24205KELGLYKSDTELLG-7.85048-9.22248
HLA-A11:014UQ24205KELGLYKSDTELLG-7.56644-8.93844
HLA-A11:014UQ24205KELGLYKSDTELLG-7.45167-8.57307
HLA-A11:014UQ24205KELGLYKSDTELLG-7.24892-9.71072
HLA-A11:014UQ24205KELGLYKSDTELLG-2.82047-5.28227
HLA-A24:025HGA4205KELGLYKSDTELLG-7.81624-8.01574
HLA-A24:025HGA4205KELGLYKSDTELLG-7.6578-7.8573
HLA-A24:025HGA4205KELGLYKSDTELLG-5.64627-7.01827
HLA-A24:025HGA4205KELGLYKSDTELLG-5.59563-8.05743
HLA-A24:025HGA4205KELGLYKSDTELLG-5.37647-6.74847
HLA-A24:025HGA4205KELGLYKSDTELLG-5.33518-6.45658
HLA-A24:025HGA4205KELGLYKSDTELLG-4.91729-7.37909
HLA-A24:025HGA4205KELGLYKSDTELLG-4.42617-5.54757
HLA-A24:025HGA4205KELGLYKSDTELLG-3.95805-6.25195
HLA-A24:025HGA4205KELGLYKSDTELLG-3.81749-6.11139
HLA-B27:056PYJ4205KELGLYKSDTELLG-5.70885-5.90835
HLA-B27:056PYJ4205KELGLYKSDTELLG-5.03282-7.49462
HLA-B27:056PYJ4205KELGLYKSDTELLG-2.40586-4.69976
HLA-B27:056PYJ4205KELGLYKSDTELLG-1.70032-3.99422
HLA-B27:056PYJ4205KELGLYKSDTELLG-0.200707-1.32211
HLA-B44:053DX84205KELGLYKSDTELLG-6.17504-7.54704
HLA-B44:053DX84205KELGLYKSDTELLG-6.03938-7.41138
HLA-B44:053DX84205KELGLYKSDTELLG-5.94458-7.06598
HLA-B44:053DX84205KELGLYKSDTELLG-5.57593-8.03773
HLA-B44:053DX84205KELGLYKSDTELLG-5.47451-5.67401
HLA-B44:053DX84205KELGLYKSDTELLG-5.33866-5.53816
HLA-B44:053DX84205KELGLYKSDTELLG-4.93454-6.05594
HLA-B44:053DX84205KELGLYKSDTELLG-4.90645-6.27845
HLA-B44:053DX84205KELGLYKSDTELLG-4.77431-4.97381
HLA-B44:053DX84205KELGLYKSDTELLG-4.49756-6.79146
HLA-B44:053DX84205KELGLYKSDTELLG-4.33503-5.45643
HLA-B44:053DX84205KELGLYKSDTELLG-3.63441-6.09621
HLA-B44:053DX84205KELGLYKSDTELLG-3.3323-5.6262
HLA-B44:053DX84205KELGLYKSDTELLG-2.60783-4.90173
HLA-B44:053DX84205KELGLYKSDTELLG-1.65363-4.11543
HLA-A02:016TDR4205KELGLYKSDTELLG-4.85416-7.31596
HLA-A02:016TDR4205KELGLYKSDTELLG-2.30987-4.77167

Top

Vaccine Design for the FusionNeoAntigens of GUK1-KDM5C

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
GUK1-KDM5Cchr1228336098chrX532281981018LYKSDTELCTCTCTGAGCCCTGAGTCCCTTGA
GUK1-KDM5Cchr1228336098chrX532281981019LYKSDTELLCTCTCTGAGCCCTGAGTCCCTTGACTT
GUK1-KDM5Cchr1228336098chrX532281981121YKSDTELLGLTCTGAGCCCTGAGTCCCTTGACTTTTGTAT
GUK1-KDM5Cchr1228336098chrX532281981221KSDTELLGLGAGCCCTGAGTCCCTTGACTTTTGTAT
GUK1-KDM5Cchr1228336098chrX53228198918GLYKSDTELGCGCTCTCTGAGCCCTGAGTCCCTTGA
GUK1-KDM5Cchr1228336098chrX53228198919GLYKSDTELLGCGCTCTCTGAGCCCTGAGTCCCTTGACTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
GUK1-KDM5Cchr1228336098chrX53228198823LGLYKSDTELLGLSAGAGGCGCTCTCTGAGCCCTGAGTCCCTTGACTTTTGTATTCTGAC

Top

Information of the samples that have these potential fusion neoantigens of GUK1-KDM5C

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
N/AGUK1-KDM5Cchr1228336098ENST00000312726chrX53228198ENST00000452825BE939838

Top

Potential target of CAR-T therapy development for GUK1-KDM5C

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to GUK1-KDM5C

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to GUK1-KDM5C

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource